Cite
HARVARD Citation
Borst, L. et al. (2022). NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division. International journal of cancer. 150 (4), pp. 688-704. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Borst, L. et al. (2022). NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division. International journal of cancer. 150 (4), pp. 688-704. [Online].